SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Montgomery Herbert D – ‘4’ for 8/27/21 re: Kindred Biosciences, Inc.

On:  Monday, 8/30/21, at 3:20pm ET   ·   For:  8/27/21   ·   Accession #:  1250853-21-86   ·   File #:  1-36225

Previous ‘4’:  ‘4’ on 1/22/21 for 1/20/21   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/30/21  Montgomery Herbert D              4                      1:15K  Kindred Biosciences, Inc.         Troy & Gould Pr… Corp/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      3K 
                Securities by an Insider -- primary_doc.xml/3.6


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
Plain Text rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0306
Document Type:  4
Period of Report:  8/27/21
Not Subject to Section 16:  1
Issuer:
Issuer CIK:  1561743
Issuer Name:  Kindred Biosciences, Inc.
Issuer Trading Symbol:  KIN
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1022265
Owner Name:  MONTGOMERY HERBERT D
Reporting Owner Address:
Owner Street 1:  C/O KINDRED BIOSCIENCES, INC.
Owner Street 2:  1555 BAYSHORE HIGHWAY, SUITE 200
Owner City:  BURLINGAME
Owner State:  CA
Owner ZIP Code:  94010
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Stock Option (right to buy)
Conversion or Exercise Price:
Value:  3.52
Transaction Date:
Value:  8/27/21
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  27,500
Transaction Price Per Share:
Value:  5.73
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F1
Expiration Date:
Value:  4/15/26
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  27,500
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (right to buy)
Conversion or Exercise Price:
Value:  4.14
Transaction Date:
Value:  8/27/21
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  3,350
Transaction Price Per Share:
Value:  5.11
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F2
Expiration Date:
Value:  5/26/26
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  3,350
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (right to buy)
Conversion or Exercise Price:
Value:  6.4
Transaction Date:
Value:  8/27/21
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  49,900
Transaction Price Per Share:
Value:  2.85
Footnote ID:  F3
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F3
Expiration Date:
Value:  1/23/27
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  49,900
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (right to buy)
Conversion or Exercise Price:
Value:  8.75
Transaction Date:
Value:  8/27/21
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  75,000
Transaction Price Per Share:
Value:  0.5
Footnote ID:  F4
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F4
Expiration Date:
Value:  1/22/28
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  75,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (right to buy)
Conversion or Exercise Price:
Value:  9.91
Transaction Date:
Value:  8/27/21
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  51,500
Transaction Price Per Share:
Value:  0
Footnote ID:  F5
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F5
Expiration Date:
Value:  1/31/29
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  51,500
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (right to buy)
Conversion or Exercise Price:
Value:  9.84
Transaction Date:
Value:  8/27/21
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  51,500
Transaction Price Per Share:
Value:  0
Footnote ID:  F6
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F6
Expiration Date:
Value:  1/16/30
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  51,500
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Stock Option (right to buy)
Conversion or Exercise Price:
Value:  4.44
Transaction Date:
Value:  8/27/21
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  51,500
Transaction Price Per Share:
Value:  4.81
Footnote ID:  F7
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F7
Expiration Date:
Value:  1/19/31
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  51,500
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1:  This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement") in exchange for a cash payment of $157,575.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
Footnote - F2:  This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $17,118.50, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
Footnote - F3:  This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $142,215.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
Footnote - F4:  This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $37,500.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
Footnote - F5:  This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.
Footnote - F6:  This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.
Footnote - F7:  This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $247,715.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
Owner Signature:
Signature Name:  /s/ Herbert Montgomery
Signature Date:  8/27/21


↑Top
Filing Submission 0001250853-21-000086   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 7, 8:32:39.2pm ET